Spinal implant market, one of the largest markets in orthopedics, is being driven by favorable demographic trends and high incidence of back pain. In the US, the occurrence of lower back pain at some time in one’s lifetime is almost ninety percent. Technological advances such as minimal invasive procedures and non-fusion technologies, are also aiding in growth of the market.
Market share of larger spine companies is being gradually eroded by smaller, niche companies. Smaller players are extensively expanding their product portfolio and sales forces. Most of the product innovation is coming from small, private companies. High economic profit within the industry has driven R&D expenditures of smaller firms.
Asia-pacific region presents a major growth opportunity for the spine market with only fifteen percent of revenues of leading spine companies being derived from the region. The growing economic prosperity of countries like India and China has driven growth in orthopedic surgeries in Asia-pacific.
The global spine market is dominated by Medtronic, DePuy, Synthes, and Stryker which together control about three-fourths of the worldwide market. Mergers and acquisitions has been a key trend of the industry. In 2008, Medtronic completed the acquisition of Kyphon. Kyphon’s primary products are used in balloon kyphoplasty. Zimmer Holdings completed the acquisition of Abbott Spine while NuVasive acquired Osteocel biologics business of Osiris Therapeutics. NuVasive is a leading global pure play spine company.
The report analyzes the global and US spine market. The section on competitive landscape analyses the market share and revenues of key players in the worldwide and the US market. The report profiles the major spine companies, focusing in-depth on their business strategies.
